3.94600 EUR
0.036
0.92%
Last update Dec 17, 7:32 PM CET
Main market
Day range
3.84600
3.94600
Previous close
3.91000
Open
3.84600
Access this stock data via API
Subscribe
Arbutus Biopharma Corporation
3.95
0.04
0.92%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 451.0K 9.2M 1.5M 1.3M
Cost of revenue
Gross profit
Operating expense
Research & development 4.9M 4.7M 7.6M 7.5M
Selling general and admin 2.6M 2.8M 5.0M 4.0M
Other operating expenses
Operating income -7.1M 1.6M -11.1M -10.2M
Non operating interest income
Income 811.6K 888.3K 1.0M 1.2M
Expense 19.6K 23.9K 23.9K 25.6K
Other income expense -322.2K -344.4K -10.8M -1.7M
Pretax income -6.6M 2.2M -20.9M -10.7M
Tax provision
Net income -6.6M 2.2M -20.9M -10.7M
Basic EPS 0.0 0.0 -0.1
Diluted EPS 0.0 0.0 -0.1
Basic average shares 163.5M 163.3M 162.6M
Diluted average shares 163.5M 164.0M 162.6M
EBITDA -6.2M 2.5M -9.8M -8.7M
Net income from continuing op. -6.6M 2.2M -20.9M -10.7M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 8 hours 26 minutes

11:33
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).